Cargando…
Quality compliance in the development of cell-based medicines in non-pharma environments
Autores principales: | Oliver-Vila, Irene, van Deusen, Amy L, Palau, Roger, Vives, Joaquim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4685435/ http://dx.doi.org/10.1186/1753-6561-9-S9-P29 |
Ejemplares similares
-
Ex vivo production of red blood cells from human cord blood
por: Caminal, Marta, et al.
Publicado: (2015) -
Off-the-shelf mesenchymal stromal cells derived from umbilical cord tissue
por: Oliver-Vila, Irene, et al.
Publicado: (2015) -
Compliance in Non-Clinical Development of Cell-, Gene-, and Tissue-Based Medicines: Good Practice for Better Therapies
por: Lopez-Navas, Luis, et al.
Publicado: (2022) -
BigPharma and unethical marketing of medicinal products
por: Myhr, Kirsten
Publicado: (2011) -
The Image of Pharma
Publicado: (2007)